The rise of copyright’s blockbuster initially sparked a boom for pharma, but recent changes present a murky picture for shareholders. Lower-cost competitors are eroding revenue, and continued litigation add further https://abelizga369166.acidblog.net/72431585/viagra-and-big-pharma-a-volatile-bet